What is NDC 69238-2577?

69238-2577 is the product NDC for Carvedilol Phosphate, Carvedilol phosphate 10 mg/1 capsule, extended release, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Carvedilol Phosphate?

28 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Carvedilol Phosphate NDC 69238-2577

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-2577Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-2577Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
69238-2577-1	6923825770169238257701	100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-2577-1)Marketed from Aug 1, 2023
69238-2577-2	6923825770269238257702	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-2577-2)Marketed from Aug 1, 2023
69238-2577-3	6923825770369238257703	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-2577-3)Marketed from Aug 1, 2023
69238-2577-9	6923825770969238257709	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69238-2577-9)Marketed from Aug 1, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carvedilol Phosphate
Generic name (nonproprietary): carvedilol phosphate
Active ingredients: Carvedilol phosphate — 10 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLCNDC labeler code 69238
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204717
Marketing start: Aug 1, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)Adrenergic beta1-Antagonists (Mechanism)Adrenergic beta2-Antagonists (Mechanism)
Identifiers: Product ID 69238-2577_7bae176f-58e3-4d75-9609-80079f391e1eSPL ID 7bae176f-58e3-4d75-9609-80079f391e1eSPL set ID dbec7c4b-3db7-4c9d-b5da-e72050ee5743RxCUI 860510, 860516, 860522, 860532UNII EQT531S367
Pharmacologic class: alpha-Adrenergic Blocker; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238257701 followed by a unit qualifier and the quantity

Package 69238-2577-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 6, 2025.

Indications (excerpt from the label)

Carvedilol phosphate extended-release capsules are an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure. ( 1.1 ) left ventricular dysfunction following myocardial infarction in clinically stable patients. ( 1.2 ) hypertension. ( 1.3 ) 1.1 Heart Failure Carvedilol phosphate extended-release capsules are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions (7.4) , Clinical Studies (14.1) ]. 1.2 Left Ventricular Dysfunction follow…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69238-2577

What is NDC 69238-2577?: 69238-2577 is the product NDC for Carvedilol Phosphate, Carvedilol phosphate 10 mg/1 capsule, extended release, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Carvedilol Phosphate.
What is the active ingredient?: Carvedilol phosphate.
Who is the labeler?: Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Carvedilol Phosphate?: 28 other product NDCs are listed under this name. See all Carvedilol Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Carvedilol Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Carvedilol Phosphate	Carvedilol phosphate 10 mg/1	Capsule, Extended releaseOral	Coupler LLC	67046-1551	67046-1551-03
Carvedilol Phosphate	Carvedilol phosphate 10 mg/1	Capsule, Extended releaseOral	AvKARE	42291-479	42291-0479-30
Carvedilol Phosphate	Carvedilol phosphate 20 mg/1	Capsule, Extended releaseOral	AvKARE	42291-480	42291-0480-30
Carvedilol Phosphate	Carvedilol phosphate 40 mg/1	Capsule, Extended releaseOral	AvKARE	42291-481	42291-0481-30
Carvedilol Phosphate	Carvedilol phosphate 80 mg/1	Capsule, Extended releaseOral	AvKARE	42291-482	42291-0482-30
Carvedilol Phosphate	Carvedilol phosphate 10 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1248	00115-1248-0100115-1248-0300115-1248-08+1 more
Carvedilol Phosphate	Carvedilol phosphate 20 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1249	00115-1249-0100115-1249-0300115-1249-08+1 more
Carvedilol Phosphate	Carvedilol phosphate 40 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1250	00115-1250-0100115-1250-0300115-1250-08+1 more
Carvedilol Phosphate	Carvedilol phosphate 80 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1251	00115-1251-0100115-1251-0300115-1251-08+1 more
Carvedilol Phosphate	Carvedilol phosphate 20 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2578	69238-2578-0169238-2578-0269238-2578-03+1 more

All 29 Carvedilol Phosphate NDCs

Other NDCs under ANDA 204717

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204717
Product	Strength	Form · route	Labeler	Product NDC
Carvedilol Phosphate	Carvedilol phosphate 20 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2578
Carvedilol Phosphate	Carvedilol phosphate 40 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2579
Carvedilol Phosphate	Carvedilol phosphate 80 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2580
Carvedilol Phosphate	Carvedilol phosphate 10 mg/1	Capsule, Extended releaseOral	AvKARE	42291-479
Carvedilol Phosphate	Carvedilol phosphate 20 mg/1	Capsule, Extended releaseOral	AvKARE	42291-480
Carvedilol Phosphate	Carvedilol phosphate 40 mg/1	Capsule, Extended releaseOral	AvKARE	42291-481
Carvedilol Phosphate	Carvedilol phosphate 80 mg/1	Capsule, Extended releaseOral	AvKARE	42291-482
Carvedilol Phosphate	Carvedilol phosphate 10 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1248
Carvedilol Phosphate	Carvedilol phosphate 20 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1249
Carvedilol Phosphate	Carvedilol phosphate 40 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1250
Carvedilol Phosphate	Carvedilol phosphate 80 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1251